BIOMAT Database Logo BIOMAT Database Logo

Cyclic cyproterone/ethinyloestradiol for acne. 1983

R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe

UI MeSH Term Description Entries
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000726 Androgen Antagonists Compounds which inhibit or antagonize the biosynthesis or actions of androgens. Androgen Antagonist,Antiandrogen,Antiandrogens,Anti-Androgen Effect,Anti-Androgen Effects,Antiandrogen Effect,Antiandrogen Effects,Antagonist, Androgen,Antagonists, Androgen,Anti Androgen Effect,Anti Androgen Effects,Effect, Anti-Androgen,Effect, Antiandrogen,Effects, Anti-Androgen,Effects, Antiandrogen
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D017373 Cyproterone Acetate An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites. Androcur,Cyproterone Acetate, (1 alpha,2 alpha)-Isomer,Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer,Cyproterone Acetate, (17 alpha)-Isomer

Related Publications

R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Cyclic cyproterone/ethinyloestradiol for acne.
September 1983, Lancet (London, England),
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Cyclic cyproterone/ethinyloestradiol for acne.
August 1983, Lancet (London, England),
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Cyclic cyproterone/ethinyloestradiol in acne.
October 1983, Lancet (London, England),
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Is cyclic low dose cyproterone acetate and ethinyloestradiol effective in acne?
July 1983, Lancet (London, England),
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Prescribing pitfalls: cyproterone acetate with ethinyloestradiol.
July 2000, Community nurse,
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol.
February 1995, Lancet (London, England),
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Efficacy of combined ethinyloestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome.
November 1997, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Treatment of hirsutism and acne with cyproterone acetate.
May 1986, Clinics in endocrinology and metabolism,
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
Treatment of hirsutism, acne and alopecia with cyproterone acetate.
January 1980, Dermatologica,
R Greenwood, and B Burke, and L Brummitt, and W J Cunliffe
[Use of cyproterone acetate in the treatment of acne].
January 1982, Medicina cutanea ibero-latino-americana,
Copied contents to your clipboard!